Formula: C9H7BrN2O, New research progress on 82019-32-7 in 2021. Redox catalysis has been broadly utilized in electrochemical synthesis due to its kinetic advantages over direct electrolysis. 82019-32-7, Name is 7-Bromo-1-methyl-1H-quinoxalin-2-one, molecular formula is C9H7BrN2O. In a Patent，once mentioned of 82019-32-7
The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Formula: C9H7BrN2O, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 82019-32-7
Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1918 | ChemSpider